Synergistic glucocorticoids, vitamins, and microbiome strategies for gut protection in critical illness
The glucocorticoid receptor (GR) signaling pathway is essential for supporting the integrity of the intestinal barrier, regulating the gut microbiome, and preserving systemic homeostasis in critical
[...] Read more.
The glucocorticoid receptor (GR) signaling pathway is essential for supporting the integrity of the intestinal barrier, regulating the gut microbiome, and preserving systemic homeostasis in critically ill patients. GR signaling limits bacterial translocation and systemic inflammation by suppressing pro-inflammatory cytokines, reinforcing tight junction proteins, and promoting epithelial renewal. Additionally, physiological levels of glucocorticoids (GCs) stimulate glutamine and proline metabolism, supporting intestinal maturation, with potential clinical relevance. GR signaling modulates inter-organ communication via the gut-lung and gut-brain axes, improving outcomes. Probiotics enhance GC therapy by restoring microbial balance, increasing short-chain fatty acid (SCFA) production, and modulating immune responses. Vitamins A, C, D, and E contribute to gut resilience by stabilizing tight junctions, mitigating oxidative stress, and strengthening mucosal immunity. Specifically, vitamin D balances T-cell subsets and promotes antimicrobial peptides; vitamin C supports collagen synthesis, antioxidant defenses, and immune function; vitamin A promotes immune tolerance and epithelial regeneration; and vitamin E mitigates oxidative damage and excessive cytokine release. GCs, probiotics, and vitamins counteract key drivers of critical illness, including hyperinflammation and dysbiosis, while maintaining strong safety profiles. This integrative approach leverages these interventions’ distinct yet complementary roles to provide a multi-layered defense against gut dysfunction. GCs reduce excessive inflammation and restore immune balance; probiotics enhance microbial diversity and strengthen gut-associated immunity; and vitamins support epithelial integrity and antioxidant defenses. Targeting multiple pathways simultaneously protects the gut barrier and modulates systemic immunity, potentially reducing complications such as sepsis, multiple organ dysfunction syndrome (MODS), and prolonged intensive care unit (ICU) stays. Incorporating these elements into critical care practice offers a novel strategy to mitigate gut dysfunction, reduce systemic inflammation, and enhance immune resilience. This approach may lower infection rates, decrease the incidence of sepsis and MODS, and accelerate recovery by targeting GR signaling, restoring microbial homeostasis, and reinforcing epithelial integrity.
Gianfranco Umberto Meduri
View:104
Download:11
Times Cited: 0
The glucocorticoid receptor (GR) signaling pathway is essential for supporting the integrity of the intestinal barrier, regulating the gut microbiome, and preserving systemic homeostasis in critically ill patients. GR signaling limits bacterial translocation and systemic inflammation by suppressing pro-inflammatory cytokines, reinforcing tight junction proteins, and promoting epithelial renewal. Additionally, physiological levels of glucocorticoids (GCs) stimulate glutamine and proline metabolism, supporting intestinal maturation, with potential clinical relevance. GR signaling modulates inter-organ communication via the gut-lung and gut-brain axes, improving outcomes. Probiotics enhance GC therapy by restoring microbial balance, increasing short-chain fatty acid (SCFA) production, and modulating immune responses. Vitamins A, C, D, and E contribute to gut resilience by stabilizing tight junctions, mitigating oxidative stress, and strengthening mucosal immunity. Specifically, vitamin D balances T-cell subsets and promotes antimicrobial peptides; vitamin C supports collagen synthesis, antioxidant defenses, and immune function; vitamin A promotes immune tolerance and epithelial regeneration; and vitamin E mitigates oxidative damage and excessive cytokine release. GCs, probiotics, and vitamins counteract key drivers of critical illness, including hyperinflammation and dysbiosis, while maintaining strong safety profiles. This integrative approach leverages these interventions’ distinct yet complementary roles to provide a multi-layered defense against gut dysfunction. GCs reduce excessive inflammation and restore immune balance; probiotics enhance microbial diversity and strengthen gut-associated immunity; and vitamins support epithelial integrity and antioxidant defenses. Targeting multiple pathways simultaneously protects the gut barrier and modulates systemic immunity, potentially reducing complications such as sepsis, multiple organ dysfunction syndrome (MODS), and prolonged intensive care unit (ICU) stays. Incorporating these elements into critical care practice offers a novel strategy to mitigate gut dysfunction, reduce systemic inflammation, and enhance immune resilience. This approach may lower infection rates, decrease the incidence of sepsis and MODS, and accelerate recovery by targeting GR signaling, restoring microbial homeostasis, and reinforcing epithelial integrity.